623 related articles for article (PubMed ID: 23663742)
1. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
2. Metabolism: Adiponectin---a mediator of specific metabolic actions of FGF21.
Goetz R
Nat Rev Endocrinol; 2013 Sep; 9(9):506-8. PubMed ID: 23856819
[No Abstract] [Full Text] [Related]
3. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
5. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
6. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
7. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
[TBL] [Abstract][Full Text] [Related]
10. Weight Loss and Concomitant Adipose Autophagy in Methionine-Restricted Obese Mice is Not Dependent on Adiponectin or FGF21.
Cooke D; Mattocks D; Nichenametla SN; Anunciado-Koza RP; Koza RA; Ables GP
Obesity (Silver Spring); 2020 Jun; 28(6):1075-1085. PubMed ID: 32348021
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
12. Central Resistin/TLR4 Impairs Adiponectin Signaling, Contributing to Insulin and FGF21 Resistance.
Benomar Y; Amine H; Crépin D; Al Rifai S; Riffault L; Gertler A; Taouis M
Diabetes; 2016 Apr; 65(4):913-26. PubMed ID: 26740596
[TBL] [Abstract][Full Text] [Related]
13. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
[TBL] [Abstract][Full Text] [Related]
16. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
Berglund ED; Li CY; Bina HA; Lynes SE; Michael MD; Shanafelt AB; Kharitonenkov A; Wasserman DH
Endocrinology; 2009 Sep; 150(9):4084-93. PubMed ID: 19470704
[TBL] [Abstract][Full Text] [Related]
18. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
Liu Q; Liu Y; Li F; Gu Z; Liu M; Shao T; Zhang L; Zhou G; Pan C; He L; Cai J; Zhang X; Barve S; McClain CJ; Chen Y; Feng W
J Nutr Biochem; 2020 Jan; 75():108256. PubMed ID: 31760308
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action.
Krumm CS; Giesy SL; Caixeta LS; Perfield JW; Sauerwein H; Moore BL; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11586-11596. PubMed ID: 31548053
[TBL] [Abstract][Full Text] [Related]
20. The FGF21-adiponectin axis in controlling energy and vascular homeostasis.
Hui X; Feng T; Liu Q; Gao Y; Xu A
J Mol Cell Biol; 2016 Apr; 8(2):110-9. PubMed ID: 26993043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]